{"title": "Bisphosphonates increasingly prescribed to the women most likely to benefit", "title_detail": {"type": "text/plain", "language": null, "base": "https://www.sciencedaily.com/rss/health_medicine/pharmacology.xml", "value": "Bisphosphonates increasingly prescribed to the women most likely to benefit"}, "links": [{"rel": "alternate", "type": "text/html", "href": "https://www.sciencedaily.com/releases/2019/03/190323145159.htm"}], "link": "https://www.sciencedaily.com/releases/2019/03/190323145159.htm", "summary": "In recent years, women who start taking bisphosphonates (BPs) to treat osteoporosis and prevent fracture have trended from younger to older and from having osteopenia to having osteoporosis, researchers report.", "summary_detail": {"type": "text/html", "language": null, "base": "https://www.sciencedaily.com/rss/health_medicine/pharmacology.xml", "value": "In recent years, women who start taking bisphosphonates (BPs) to treat osteoporosis and prevent fracture have trended from younger to older and from having osteopenia to having osteoporosis, researchers report."}, "published": "Sat, 23 Mar 2019 14:51:59 EDT", "published_parsed": [2019, 3, 23, 18, 51, 59, 5, 82, 0], "id": "https://www.sciencedaily.com/releases/2019/03/190323145159.htm", "guidislink": false}